We are live on
!
Find out more
BIA
Biondo Investment Advisors Portfolio holdings
AUM
$780M
1-Year Est. Return
21.03%
This Fund
S&P 500
This Quarter
Est. Return
-17.81%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$454M
AUM Growth
-$113M
(-20%)
Cap. Flow
+$442M
Cap. Flow
% of AUM
97.29%
Top 10 Holdings %
Top 10 Hldgs %
43.03%
Holding
80
New
1
Increased
58
Reduced
12
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$437M |
| 2 |
Illumina
ILMN
|
+$2.02M |
| 3 |
Idexx Laboratories
IDXX
|
+$1.54M |
| 4 |
Intuitive Surgical
ISRG
|
+$1.43M |
| 5 |
SIVB
SVB Financial Group
SIVB
|
+$1.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioCryst Pharmaceuticals
BCRX
|
+$4.25M |
| 2 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$3.4M |
| 3 |
Iovance Biotherapeutics
IOVA
|
+$3.04M |
| 4 |
Coinbase
COIN
|
+$585K |
| 5 |
Apple
AAPL
|
+$436K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.65% |
| 2 | Technology | 19.55% |
| 3 | Financials | 11.41% |
| 4 | Consumer Discretionary | 8.8% |
| 5 | Communication Services | 6.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.89T
| $38.5M | 8.47% |
281,302
-2,880
| -1% | -$436K |
|
|
2
Intuitive Surgical
ISRG
$121B
| $28.6M | 6.3% |
142,540
+6,091
| +4% | +$1.43M |
|
3
Mastercard
MA
$477B
| $23.6M | 5.21% |
74,945
+1,017
| +1% | +$350K |
|
|
4
Alphabet (Google) Class A
GOOGL
$3.91T
| $21.3M | 4.68% |
3,901,800
+3,712,660
| +1,963% | +$437M |
|
|
ABMD
5
DELISTED
Abiomed Inc
ABMD
| $19M | 4.19% |
76,824
+791
| +1% | +$213K |
|
|
6
Idexx Laboratories
IDXX
$42.9B
| $15.7M | 3.47% |
44,872
+3,782
| +9% | +$1.54M |
|
7
ExxonMobil
XOM
$651B
| $13.3M | 2.93% |
153,663
+3,249
| +2% | +$293K |
|
8
Microsoft
MSFT
$2.84T
| $12.2M | 2.68% |
47,293
+1,721
| +4% | +$467K |
|
9
Amazon
AMZN
$2.5T
| $11.7M | 2.58% |
110,265
+1,885
| +2% | +$236K |
|
10
AbbVie
ABBV
$458B
| $11.5M | 2.54% |
75,222
+2,027
| +3% | +$310K |
|
11
Edwards Lifesciences
EW
$47.6B
| $11M | 2.42% |
115,564
-3,694
| -3% | -$382K |
|
12
Lowe's Companies
LOW
$116B
| $10.6M | 2.33% |
60,572
+2,295
| +4% | +$443K |
|
13
Adobe
ADBE
$89.5B
| $10.4M | 2.29% |
28,362
-448
| -2% | -$182K |
|
14
Procter & Gamble
PG
$343B
| $10.2M | 2.26% |
71,263
+2,750
| +4% | +$413K |
|
15
JPMorgan Chase
JPM
$939B
| $10.2M | 2.25% |
90,832
+3,040
| +3% | +$377K |
|
16
Chevron
CVX
$388B
| $9.29M | 2.05% |
63,535
+1,822
| +3% | +$301K |
|
|
SIVB
17
DELISTED
SVB Financial Group
SIVB
| $9.27M | 2.04% |
23,476
+2,448
| +12% | +$1.15M |
|
18
McDonald's
MCD
$188B
| $9.09M | 2% |
36,823
+1,560
| +4% | +$384K |
|
19
Johnson & Johnson
JNJ
$634B
| $8.85M | 1.95% |
49,540
+2,005
| +4% | +$357K |
|
20
Bristol-Myers Squibb
BMY
$127B
| $8.85M | 1.95% |
114,894
+3,340
| +3% | +$254K |
|
|
21
Illumina
ILMN
$29.4B
| $8.64M | 1.9% |
48,186
+7,913
| +20% | +$2.02M |
|
22
Southern Company
SO
$110B
| $8.51M | 1.87% |
118,191
+4,186
| +4% | +$307K |
|
|
XYZ
23
Block Inc
XYZ
$45.9B
| $8.45M | 1.86% |
137,469
+2,041
| +2% | +$186K |
|
24
Lockheed Martin
LMT
$134B
| $8.27M | 1.82% |
19,119
+724
| +4% | +$318K |
|
25
General Mills
GIS
$19.2B
| $7.94M | 1.75% |
105,190
+2,940
| +3% | +$206K |
|
Similar funds
LA
UBV
SG
RTM
TCMX
QCMNJ
TIS
MO
Biondo Investment Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Biondo Investment Advisors held 80 positions worth $454M, down 20% from $568M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Biondo Investment Advisors deployed $442M of net new capital in Q2 2022, opening 1 new position and adding to 58 existing holdings. Its largest new stake was Wells Fargo: 16,388 shares worth $643K.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Bed Bath & Beyond Inc, an estimated $3.4M trimmed.
- Biondo Investment Advisors's largest Q2 2022 buy was Wells Fargo: 16,388 shares worth $643K.
- Biondo Investment Advisors added most to Alphabet (Google) Class A in Q2 2022, an estimated $437M increase.
- Biondo Investment Advisors's biggest Q2 2022 reduction was Bed Bath & Beyond Inc, cutting an estimated $3.4M.
- Biondo Investment Advisors fully exited BioCryst Pharmaceuticals in Q2 2022, selling an estimated $4.25M.
- Biondo Investment Advisors's ten largest holdings make up 43% of its $454M portfolio in Q2 2022.
- Biondo Investment Advisors opened 1 new position and closed 4 in Q2 2022.
- Biondo Investment Advisors's portfolio value fell 20% quarter-over-quarter to $454M.
Based on Biondo Investment Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.